Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

Articolo
Data di Pubblicazione:
2021
Citazione:
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial / de Groot, Pieter; Nicolic, Tanja; Pellegrini, Silvia; Sordi, Valeria; Imangaliyev, Sultan; Rampanelli, Elena; Hanssen, Nordin; Attaye, Ilias; Bakker, Guido; Duinkerken, Gaby; Joosten, Annemarie; Prodan, Andrei; Levin, Evgeni; Levels, Han; Potter van Loon, Bartjan; van Bon, Arianne; Brouwer, Catherina; van Dam, Sytze; Simsek, Suat; van Raalte, Daniel; Stam, Frank; Gerdes, Victor; Hoogma, Roel; Diekman, Martin; Gerding, Martin; Rustemeijer, Cees; de Bakker, Bernadette; Hoekstra, Joost; Zwinderman, Aeilko; Bergman, Jacques; Holleman, Frits; Piemonti, Lorenzo; De Vos, Willem; Roep, Bart; Nieuwdorp, Max. - In: GUT. - ISSN 0017-5749. - 70:1(2021), pp. 92-105. [Epub ahead of print] [10.1136/gutjnl-2020-322630]
Abstract:
Type 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota-immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota transplantation (FMT).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
diabetes mellitus
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/106087
Pubblicato in:
GUT
Journal